Even though up to 1 in 3 people with schizophrenia had their first psychotic episode as an adolescent, 2 new randomized studies are among the first to explore the use of antipsychotic medications in this young population.
Medscape Medical News
New Trials of Antipsychotics in Children Published
Published in November 6th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
Improving Healthcare Through Pharmacy-Performance Measurement: An Expert Interview With Laura J. Cranston, RPh
Published in November 6th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
The Pharmacy Quality Alliance aims to improve healthcare quality and patient safety by measuring pharmacy and pharmacist performance.
Medscape Medical News
FDA Approvals: Apidra, LoSeasonique, Precedex
Published in November 6th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
The FDA has approved an expanded indication for insulin glulisine injection (Apidra), an oral contraceptive regimen (LoSeasonique); and a new indication for dexmedetomidine HCl infusion (Precedex).
Medscape Medical News
Antibiotic Prophylaxis May Not Reduce Recurrent Febrile Urinary Tract Infection
Published in November 6th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
In a randomized controlled trial, antibiotic prophylaxis did not reduce the rate of febrile urinary tract infection recurrence in children with or without primary nonsevere vesicoureteral reflux.
Medscape Medical News
Antihypertensive Treatment in the Very Elderly: An Expert Interview With Mandy R. Torres, PharmD, BCPS, FASCP
Published in November 6th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
Presentations at the 2008 American College of Clinical Pharmacy annual meeting highlighted the pros and cons of treating hypertension in the 80-plus population.
Medscape Medical News
Triple Therapies Offer Promising Results for Hepatitis C
Published in November 6th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
The addition of boceprevir or telaprevir improved the sustained virologic response rate about 20% to 40%.
Medscape Medical News
AASLD 2008: Triple Therapies Offer Promising Results for Hepatitis C
Published in November 6th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
The addition of boceprevir or telaprevir improved the sustained virologic response rate about 20% to 40%.
Medscape Medical News
OraQuick ADVANCE Rapid HIV-1/2 Antibody Test To Be Sold Directly To U.S. Hospitals Starting 2009
Published in November 6th, 2008
Posted by Pharma Industry / Biotech Industry News From Medical News Today in Pharmaceutical Industry News
Comments Off
OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced that it will begin to sell its OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test directly into the U.S. hospital market beginning in 2009. In recent years, the U.S. hospital market has received this product through an exclusive distribution arrangement with Abbott.
Letter, Opinion Piece Address Supreme Court Case Regarding Drug Safety, Federal Pre-Emption
Published in November 6th, 2008
Posted by Pharma Industry / Biotech Industry News From Medical News Today in Pharmaceutical Industry News
Comments Off
The U.S. Supreme Court on Monday heard opening arguments in Wyeth v. Levine, a case that could determine whether patients have the ability to file product liability lawsuits against pharmaceutical companies in state courts (Kaiser Daily Health Policy Report, 11/4).
FDA Seizes Contaminated Heparin from a Cincinnati Manufacturer
Published in November 6th, 2008
Comments Off
The five lots of Heparin Sodium Active Pharmaceutical Ingredient (API) and six lots of Heparin Lithium were seized at the FDA’s request by U.S. Marshals. These products, which were manufactured from material imported from China, had been found by the agency to be contaminated with over-sulfated chondroitin sulfate (OSCS), a substance that mimics heparin’s anticoagulant activity.